BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 26739236)

  • 21. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex.
    Balasubramani A; Larjo A; Bassein JA; Chang X; Hastie RB; Togher SM; Lähdesmäki H; Rao A
    Nat Commun; 2015 Jun; 6():7307. PubMed ID: 26095772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis of histone H2A lysine 119 deubiquitination by Polycomb Repressive Deubiquitinase BAP1/ASXL1.
    Thomas JF; Valencia-Sánchez MI; Tamburri S; Gloor SL; Rustichelli S; Godínez-López V; De Ioannes P; Lee R; Abini-Agbomson S; Gretarsson K; Burg JM; Hickman AR; Sun L; Gopinath S; Taylor H; Meiners MJ; Cheek MA; Rice W; Nudler E; Lu C; Keogh MC; Pasini D; Armache KJ
    bioRxiv; 2023 Feb; ():. PubMed ID: 36865140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication.
    Klusmann I; Wohlberedt K; Magerhans A; Teloni F; Korbel JO; Altmeyer M; Dobbelstein M
    Proc Natl Acad Sci U S A; 2018 Nov; 115(48):E11311-E11320. PubMed ID: 30413623
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulation of B Lymphocyte Development by Histone H2A Deubiquitinase BAP1.
    Lin YH; Liang Y; Wang H; Tung LT; Förster M; Subramani PG; Di Noia JM; Clare S; Langlais D; Nijnik A
    Front Immunol; 2021; 12():626418. PubMed ID: 33912157
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PR-DUB maintains the expression of critical genes through FOXK1/2- and ASXL1/2/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination.
    Kolovos P; Nishimura K; Sankar A; Sidoli S; Cloos PA; Helin K; Christensen J
    Genome Res; 2020 Aug; 30(8):1119-1130. PubMed ID: 32747411
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic targeted therapy of stabilized BAP1 in ASXL1 gain-of-function mutated leukemia.
    Wang L; Birch NW; Zhao Z; Nestler CM; Kazmer A; Shilati A; Blake A; Ozark PA; Rendleman EJ; Zha D; Ryan CA; Morgan MAJ; Shilatifard A
    Nat Cancer; 2021 May; 2(5):515-526. PubMed ID: 35122023
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BAP1 constrains pervasive H2AK119ub1 to control the transcriptional potential of the genome.
    Fursova NA; Turberfield AH; Blackledge NP; Findlater EL; Lastuvkova A; Huseyin MK; Dobrinić P; Klose RJ
    Genes Dev; 2021 May; 35(9-10):749-770. PubMed ID: 33888563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.
    Yu H; Mashtalir N; Daou S; Hammond-Martel I; Ross J; Sui G; Hart GW; Rauscher FJ; Drobetsky E; Milot E; Shi Y; Affar el B
    Mol Cell Biol; 2010 Nov; 30(21):5071-85. PubMed ID: 20805357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Additional sex combs-like 2 is required for polycomb repressive complex 2 binding at select targets.
    Lai HL; Wang QT
    PLoS One; 2013; 8(9):e73983. PubMed ID: 24040135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1-associated protein 1 (BAP1) deubiquitinase antagonizes the ubiquitin-mediated activation of FoxK2 target genes.
    Okino Y; Machida Y; Frankland-Searby S; Machida YJ
    J Biol Chem; 2015 Jan; 290(3):1580-91. PubMed ID: 25451922
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Loss of the tumor suppressor BAP1 causes myeloid transformation.
    Dey A; Seshasayee D; Noubade R; French DM; Liu J; Chaurushiya MS; Kirkpatrick DS; Pham VC; Lill JR; Bakalarski CE; Wu J; Phu L; Katavolos P; LaFave LM; Abdel-Wahab O; Modrusan Z; Seshagiri S; Dong K; Lin Z; Balazs M; Suriben R; Newton K; Hymowitz S; Garcia-Manero G; Martin F; Levine RL; Dixit VM
    Science; 2012 Sep; 337(6101):1541-6. PubMed ID: 22878500
    [TBL] [Abstract][Full Text] [Related]  

  • 32. BAP1 Is a Novel Target in HPV-Negative Head and Neck Cancer.
    Liu X; Kumar M; Yang L; Molkentine DP; Valdecanas D; Yu S; Meyn RE; Heymach JV; Skinner HD
    Clin Cancer Res; 2018 Feb; 24(3):600-607. PubMed ID: 29113987
    [No Abstract]   [Full Text] [Related]  

  • 33. Role of histone H2A ubiquitination in Polycomb silencing.
    Wang H; Wang L; Erdjument-Bromage H; Vidal M; Tempst P; Jones RS; Zhang Y
    Nature; 2004 Oct; 431(7010):873-8. PubMed ID: 15386022
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic targeting of BAP1/ASXL3 sub-complex in ASCL1-dependent small cell lung cancer.
    Tsuboyama N; Wang R; Szczepanski AP; Chen H; Zhao Z; Shi L; Wang L
    Oncogene; 2022 Apr; 41(15):2152-2162. PubMed ID: 35194152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor suppressor BAP1 is essential for thymic development and proliferative responses of T lymphocytes.
    Arenzana TL; Lianoglou S; Seki A; Eidenschenk C; Cheung T; Seshasayee D; Hagenbeek T; Sambandam A; Noubade R; Peng I; Lesch J; DeVoss J; Wu X; Lee WP; Caplazi P; Webster J; Liu J; Pham VC; Arnott D; Lill JR; Modrusan Z; Dey A; Rutz S
    Sci Immunol; 2018 Apr; 3(22):. PubMed ID: 29678836
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A common ancestry for BAP1 and Uch37 regulators.
    Sanchez-Pulido L; Kong L; Ponting CP
    Bioinformatics; 2012 Aug; 28(15):1953-6. PubMed ID: 22645167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids.
    Artegiani B; van Voorthuijsen L; Lindeboom RGH; Seinstra D; Heo I; Tapia P; López-Iglesias C; Postrach D; Dayton T; Oka R; Hu H; van Boxtel R; van Es JH; Offerhaus J; Peters PJ; van Rheenen J; Vermeulen M; Clevers H
    Cell Stem Cell; 2019 Jun; 24(6):927-943.e6. PubMed ID: 31130514
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Deregulation of tumor suppressive ASXL1-PTEN/AKT axis in myeloid malignancies.
    Cao L; Xia X; Kong Y; Jia F; Yuan B; Li R; Li Q; Wang Y; Cui M; Dai Z; Zheng H; Christensen J; Zhou Y; Wu X
    J Mol Cell Biol; 2020 Sep; 12(9):688-699. PubMed ID: 32236560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.
    Küry S; Ebstein F; Mollé A; Besnard T; Lee MK; Vignard V; Hery T; Nizon M; Mancini GMS; Giltay JC; Cogné B; McWalter K; Deb W; Mor-Shaked H; Li H; Schnur RE; Wentzensen IM; Denommé-Pichon AS; Fourgeux C; Verheijen FW; Faurie E; Schot R; Stevens CA; Smits DJ; Barr E; Sheffer R; Bernstein JA; Stimach CL; Kovitch E; Shashi V; Schoch K; Smith W; van Jaarsveld RH; Hurst ACE; Smith K; Baugh EH; Bohm SG; Vyhnálková E; Ryba L; Delnatte C; Neira J; Bonneau D; Toutain A; Rosenfeld JA; ; Audebert-Bellanger S; Gilbert-Dussardier B; Odent S; Laumonnier F; Berger SI; Smith ACM; Bourdeaut F; Stern MH; Redon R; Krüger E; Margueron R; Bézieau S; Poschmann J; Isidor B
    Am J Hum Genet; 2022 Feb; 109(2):361-372. PubMed ID: 35051358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion.
    Perez-Garcia V; Lea G; Lopez-Jimenez P; Okkenhaug H; Burton GJ; Moffett A; Turco MY; Hemberger M
    Elife; 2021 Jun; 10():. PubMed ID: 34170818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.